The 8th Annual BFC HealthCare Conference will be held on January 12 2025 at The St. Regis, San Francisco.
During the last three years, we have seen explosive growth in out-licensing of Chinese innovations to global biopharma companies.
In the past year, we have continued to see a surge in out-licensing deals between Chinese biotech firms and global pharmaceutical companies, signaling the growing influence of China's innovation in the global life sciences market. These partnerships are fueled by groundbreaking scientific achievements from leading Chinese biotech companies. However, despite these notable strides, significant challenges remain, such as reimbursement hurdles, commercialization pathways, securing venture financing, and navigating global market entry. This year's conference aims to further accelerate industry growth by fostering collaboration and knowledge exchange among key stakeholders around the globe.
Senior executives from more than 600 public & private healthcare companies across the biopharmaceuticals and biotech sectors attended our previous event in 2024. More than 300 PE and VC investors from over 100 firms were also present. The conference is an ideal setting for networking with the senior executives of your potential partners. Company management teams and investors will be able to participate in one-on-one and small-group meetings through BFC Group.
